Evidence map›Paper›PMID 34327248›Full record

ArticleOpen forum infectious diseases2021

Can't Work From Home: Pooled Nucleic Acid Testing of Laboratory Workers During the COVID-19 Pandemic.

Stephen A Rawlings, Brianna Scott, Laura Layman, Pramod Naranatt, Roy Heltsley, Caroline Ignacio, Magali Porrachia, Sara Gianella, Davey Smith, Antoine Chaillon

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Healthcare Innovations to Address the Challenges of the COVID-19 Pandemic.IEEE journal of biomedical and health informatics · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stephen A RawlingsDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.
Brianna ScottDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.
Laura LaymanDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.
Pramod NaranattFluxergy INC, Irvine, California, USA.
Roy HeltsleyFluxergy INC, Irvine, California, USA.
Caroline IgnacioDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.
Magali PorrachiaDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.
Sara GianellaDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.
Davey SmithDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.
Antoine ChaillonDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
HOPE Training GrantT32AI007384 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sara Gianella Weibel, Scott L Letendre · 1990 to 2026
$9.7M
NIAID NIH HHS P30 AI036214NIAID NIH HHS T32 AI007384NIMH NIH HHS P30 MH062512
6 · The paper itself

Abstract

Together with protective measures, routine screening for severe acute respiratory syndrome coronavirus 2 infection helps provide a safe working environment. We evaluated a pooled nucleic acid testing strategy in a research laboratory. It allowed lab activity to be maintained and would save 25 920 person-hours and $1 684 800/year by increasing the margin of safety for returning to work.

Indexed as

cost-effectivepoolingSARS-CoV-2screening

Identifiers

PMID34327248
PMCPMC7989168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.